Skip to content
CheckOrphan
  • Home
  • About Us
  • Log In
  • News
    • All News
    • Finance
    • Treatment
    • People
    • Research
  • Videos
  • Treatments
  • Clinical Trials
  • Access Programs
    • About Access Programs
  • Diseases
  • Events
  • Networks
  • Research
Main Menu

Subscribe for Free Newsletter

Email *

Type *

* Required Field
Email Marketing Services by Benchmark

Generate RSS

  1. Home
  2. /
  3. Treatment
  4. /
  5. DNA plasmid encoding the...

DNA plasmid encoding the acetylcholine receptor

February 8, 2015[email protected]
DNA plasmid encoding the acetylcholine receptor
Trade Name
Orphan Indication Myasthenia gravis Myasthenia gravis
USA Market Approval USA
USA Designation Date 2011-04-18 00:00:00
Sponsor Bayhill Therapeutics;1804 Embarcadero Rd., Suite 201;Palo Alto, California, 94303
Learn more about:
Myasthenia gravis

Related Treatment

  • Mutated form of human acetylcholine receptor a1 extracellular domain s
  • Immune globulin (human)
  • Amifampridine phosphate
  • Fusion proteins composed by a genetically modified cholera toxin subun
  • Eculizumab
More Treatment
pw

About CheckOrphan

CheckOrphan is a non-profit organization located in Basel, Switzerland and Santa Cruz, California that is dedicated to rare, orphan and neglected diseases. CheckOrphan offers users an interactive and dynamic platform for all these diseases. This strategy allows visitors to be updated daily on all the latest news and interact with people internationally. This is essential, because due to the nature of these diseases, there is not a large concentration of individuals within any given proximity.
Click here to know more About Us

Your email is important to us

Each email is sent to a CheckOrphan staff member and will be answered. We only use a contact form to avoid spam.

    Copyright © 2025 CheckOrphan.
    Developed by: Gonza.io logo Developed by: WebOptimalSolutions Powered by: Cloudscale logo